83 filings
Page 3 of 5
424B5
vi3v58k
17 Aug 22
Prospectus supplement for primary offering
4:23pm
EFFECT
hzjome4ny
17 Aug 22
Notice of effectiveness
12:15am
CORRESP
qdzz 2svyf3nvmr
12 Aug 22
Correspondence with SEC
12:00am
UPLOAD
niq1f0 0nldpn6xfi6
11 Aug 22
Letter from SEC
12:00am
S-3
7em4 m99f4n8kp
10 Aug 22
Shelf registration
8:35am
8-K
o4hhaz727mog8y pgk3l
10 Aug 22
Nuvalent Highlights Execution Across Pipeline of Novel Kinase Inhibitors and Reports Second Quarter 2022 Financial Results
12:00am
8-K
8a8ww4 6enbkjsxk
21 Jun 22
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
r0flcxtu2g csx7p
12 May 22
Nuvalent Highlights Pipeline and Business Progress and Reports First Quarter 2022 Financial Results
6:45am
DEFA14A
ougl fv7pihpll4j
29 Apr 22
Additional proxy soliciting materials
4:10pm
DEF 14A
xiko 3hl2k2z0d
29 Apr 22
Definitive proxy
4:07pm
8-K
qflxo lirxg13jy7ky
31 Mar 22
Departure of Directors or Certain Officers
6:48am
S-8
v5x2anzdp se
29 Mar 22
Registration of securities for employees
7:31am
10-K
5g5y2 ntuhduarz
29 Mar 22
Annual report
7:21am
8-K
av7kxkqq sq3swkh4o
29 Mar 22
Nuvalent Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results
6:58am
8-K
8n7fwf3rw95ayfzvlrxb
3 Feb 22
Departure of Directors or Certain Officers
6:46am
8-K
rixp3rauqb9y 6p6vyjw
7 Jan 22
Results of Operations and Financial Condition
6:40am
8-K
zx1x38y8nkszqtujez2
10 Nov 21
Nuvalent Reports Pipeline Progress and Third Quarter 2021 Financial Results
6:44am